CARBIDOPA TABLETS

CARBIDOPA TABLETS was reported 3038 times

CARBIDOPA TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXFOLIATION GLAUCOMA 2 0.0714
1 VASCULAR ENCEPHALOPATHY 17 0.0599
2 SUPINE HYPERTENSION 11 0.0582
3 AMIMIA 6 0.0545
4 DEVICE EFFECT DECREASED 2 0.0513
5 OEDEMA DUE TO CARDIAC DISEASE 6 0.0429
6 ANAL CANDIDIASIS 2 0.0345
7 DELUSION OF REPLACEMENT 3 0.0300
8 CATABOLIC STATE 2 0.0299
9 PARKINSONISM HYPERPYREXIA SYNDROME 5 0.0279
10 STOMA SITE ODOUR 6 0.0268
11 MEDICAL DEVICE BATTERY REPLACEMENT 3 0.0222
12 PATIENT ELOPEMENT 8 0.0219
13 SOFT TISSUE MASS 10 0.0216
14 PARKINSONIAN REST TREMOR 4 0.0212
15 CONFUSIONAL AROUSAL 3 0.0186
16 MESENTERIC ARTERY THROMBOSIS 7 0.0182
17 STOMA SITE DISCOMFORT 4 0.0176
18 CATHETER SITE DISCOLOURATION 2 0.0164
19 DOPAMINE DYSREGULATION SYNDROME 6 0.0135
20 SEASONAL AFFECTIVE DISORDER 4 0.0126
21 NEURODEGENERATIVE DISORDER 7 0.0113
22 DELUSION OF GRANDEUR 5 0.0111
23 HAEMANGIOMA OF BONE 2 0.0105
24 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 4 0.0100
25 DEEP BRAIN STIMULATION 6 0.0099
26 PARKINSON'S DISEASE 25 0.0098
27 ANTICHOLINERGIC SYNDROME 15 0.0094
28 HEAT ILLNESS 6 0.0089
29 ENTERAL NUTRITION 5 0.0086
30 MULTIPLE SYSTEM ATROPHY 3 0.0085
31 LIPIDS ABNORMAL 6 0.0083
32 SUBILEUS 17 0.0082
33 STOMA SITE HYPERGRANULATION 5 0.0079
34 REDUCED FACIAL EXPRESSION 8 0.0079
35 MEDICAL DEVICE CHANGE 4 0.0075
36 ON AND OFF PHENOMENON 41 0.0074
37 STOMA SITE IRRITATION 4 0.0074
38 MEDICAL DEVICE SITE PAIN 4 0.0071
39 REFLUX LARYNGITIS 3 0.0068
40 STREPTOCOCCAL BACTERAEMIA 7 0.0064
41 EUTHANASIA 2 0.0063
42 DEMENTIA WITH LEWY BODIES 7 0.0063
43 DUPLICATE THERAPY ERROR 2 0.0062
44 FREEZING PHENOMENON 23 0.0062
45 DREAMY STATE 2 0.0062
46 ILLUSION 10 0.0060
47 COMMINUTED FRACTURE 2 0.0060
48 STOMA SITE DISCHARGE 16 0.0058
49 INTERMITTENT CLAUDICATION 9 0.0057
50 ORTHOSTATIC INTOLERANCE 4 0.0056
51 HALLUCINATION, VISUAL 116 0.0055
52 PRESBYOPIA 3 0.0054
53 STOMA SITE INFECTION 7 0.0054
54 BONE FRAGMENTATION 3 0.0054
55 STOMA SITE ERYTHEMA 10 0.0053
56 STOMA SITE HAEMORRHAGE 8 0.0052
57 CARDIAC DEATH 6 0.0050
58 DELUSIONAL PERCEPTION 2 0.0048
59 PARKINSONIAN GAIT 3 0.0048
60 HYPOTONY OF EYE 2 0.0048
61 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
62 RESTING TREMOR 3 0.0046
63 CHOREA 8 0.0046
64 NONSPECIFIC REACTION 25 0.0046
65 COMPULSIONS 3 0.0045
66 STOMA SITE REACTION 3 0.0044
67 FIBROMA 4 0.0044
68 DELUSION 65 0.0042
69 INFUSION SITE NODULE 4 0.0042
70 STOMA SITE INFLAMMATION 3 0.0040
71 HALLUCINATION 299 0.0040
72 CREATINE KINASE INCREASED 3 0.0039
73 AORTIC DISORDER 3 0.0038
74 HYPERMETABOLISM 2 0.0038
75 YAWNING 10 0.0037
76 BLEEDING VARICOSE VEIN 2 0.0037
77 VERTEBRAL FORAMINAL STENOSIS 3 0.0036
78 ABDOMINAL TENDERNESS 18 0.0036
79 BRAIN SCAN ABNORMAL 2 0.0036
80 GAZE PALSY 6 0.0035
81 ADENOMA BENIGN 3 0.0035
82 DISTRACTIBILITY 4 0.0035
83 FAECALOMA 19 0.0035
84 ACUTE PRERENAL FAILURE 4 0.0035
85 AORTIC CALCIFICATION 2 0.0034
86 GASTROINTESTINAL SOUNDS ABNORMAL 17 0.0034
87 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
88 STOMA SITE PAIN 5 0.0034
89 AMBLYOPIA 2 0.0034
90 ABDOMINAL NEOPLASM 3 0.0034
91 BONE CYST 3 0.0032
92 BLADDER CATHETERISATION 3 0.0031
93 BRADYKINESIA 18 0.0030
94 PATHOLOGICAL GAMBLING 5 0.0030
95 HALLUCINATION, TACTILE 2 0.0030
96 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 3 0.0030
97 STOMA COMPLICATION 3 0.0030
98 CHOREOATHETOSIS 2 0.0029
99 CAROTID ARTERIOSCLEROSIS 3 0.0029
100 LANGUAGE DISORDER 6 0.0028
101 AORTIC VALVE SCLEROSIS 2 0.0027
102 PARESIS 6 0.0027
103 MUSCLE RIGIDITY 32 0.0027
104 CATHETER SITE DISCHARGE 3 0.0027
105 CATHETER SITE RELATED REACTION 2 0.0027
106 CHOROIDAL EFFUSION 2 0.0025
107 DEMENTIA 69 0.0025
108 PARKINSONISM 24 0.0025
109 DYSKINESIA 100 0.0025
110 BREAST OPERATION 2 0.0024
111 IMPULSE-CONTROL DISORDER 5 0.0024
112 ILEUS 30 0.0024
113 ADRENAL MASS 2 0.0024
114 PRODUCT RESIDUE PRESENT 13 0.0024
115 PERSECUTORY DELUSION 6 0.0024
116 HALLUCINATIONS, MIXED 10 0.0024
117 EYE CONTUSION 5 0.0024
118 CAROTID ARTERY DISEASE 3 0.0024
119 HYPERKINESIA 5 0.0024
120 TORTICOLLIS 5 0.0024
121 LEFT ATRIAL DILATATION 3 0.0024
122 CYSTOCELE 2 0.0023
123 CERUMEN IMPACTION 2 0.0022
124 BONE CONTUSION 2 0.0022
125 ANXIETY DISORDER 7 0.0021
126 STARING 5 0.0021
127 COLON ADENOMA 2 0.0020
128 ACQUIRED HAEMOPHILIA 2 0.0020
129 AORTIC ARTERIOSCLEROSIS 5 0.0019
130 BONE MARROW OEDEMA 2 0.0019
131 BODY TEMPERATURE FLUCTUATION 4 0.0019
132 CONSCIOUSNESS FLUCTUATING 2 0.0019
133 PERSONALITY DISORDER 5 0.0019
134 PELVIC FRACTURE 14 0.0018
135 DRUG EFFECT VARIABLE 2 0.0018
136 SENSITIVITY OF TEETH 3 0.0017
137 NEPHROGENIC ANAEMIA 8 0.0017
138 NEUROLEPTIC MALIGNANT SYNDROME 20 0.0017
139 ORTHOSTATIC HYPOTENSION 29 0.0017
140 DIABETES INSIPIDUS 4 0.0017
141 HYPOKINESIA 24 0.0017
142 HYPERSEXUALITY 3 0.0016
143 WRONG PRODUCT ADMINISTERED 11 0.0016
144 BLADDER DISORDER 16 0.0016
145 FRACTURED SACRUM 2 0.0016
146 EARLY SATIETY 3 0.0015
147 POSTURE ABNORMAL 5 0.0015
148 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0015
149 CEREBRAL ATROPHY 6 0.0015
150 PRODUCT CLEANING INADEQUATE 4 0.0015
151 DEVICE OCCLUSION 21 0.0015
152 GAMBLING DISORDER 4 0.0015
153 ORAL FUNGAL INFECTION 4 0.0015
154 COMPULSIVE SHOPPING 3 0.0015
155 PSYCHOTIC SYMPTOM 3 0.0015
156 AKINESIA 3 0.0014
157 DISCHARGE 2 0.0014
158 FORMICATION 10 0.0014
159 HIP FRACTURE 46 0.0014
160 CEREBELLAR HAEMORRHAGE 2 0.0014
161 PRODUCT ADMINISTRATION ERROR 28 0.0014
162 HYPERTONIC BLADDER 4 0.0014
163 DYSPNOEA AT REST 4 0.0014
164 SPINAL OSTEOARTHRITIS 12 0.0014
165 COCCYDYNIA 2 0.0014
166 CALCINOSIS 3 0.0013
167 HAEMORRHAGIC TRANSFORMATION STROKE 2 0.0013
168 FACE INJURY 5 0.0013
169 COMMUNICATION DISORDER 5 0.0013
170 SEROTONIN SYNDROME 24 0.0012
171 SALIVARY HYPERSECRETION 12 0.0012
172 CATHETER SITE HAEMORRHAGE 3 0.0012
173 HYPERPARATHYROIDISM SECONDARY 3 0.0012
174 PERSONALITY CHANGE 11 0.0012
175 HYPERTHERMIA 9 0.0012
176 HEPATIC LESION 5 0.0012
177 PRESCRIBED UNDERDOSE 23 0.0012
178 HYPERSOMNIA 33 0.0011
179 CATATONIA 6 0.0011
180 NASAL DISCOMFORT 9 0.0011
181 TRICUSPID VALVE INCOMPETENCE 9 0.0011
182 COMPRESSION FRACTURE 6 0.0011
183 IRON DEFICIENCY 5 0.0011
184 DEVICE ALARM ISSUE 2 0.0011
185 DEVICE KINK 4 0.0011
186 DYSTONIA 21 0.0011
187 HYPERTENSIVE HEART DISEASE 2 0.0011
188 DYSGRAPHIA 7 0.0011
189 LOSS OF CONTROL OF LEGS 4 0.0011
190 EXERCISE TOLERANCE DECREASED 6 0.0010
191 ABNORMAL BEHAVIOUR 41 0.0010
192 THERAPEUTIC PRODUCT EFFECT VARIABLE 4 0.0010
193 LUMBAR SPINAL STENOSIS 3 0.0010
194 EYE MOVEMENT DISORDER 7 0.0010
195 MYOCLONUS 12 0.0010
196 DYSSTASIA 29 0.0010
197 CARDIAC DISCOMFORT 2 0.0010
198 REBOUND ACID HYPERSECRETION 3 0.0010
199 RESTLESS LEGS SYNDROME 18 0.0010
200 TENSION 6 0.0010
201 AMMONIA INCREASED 5 0.0010
202 GOITRE 4 0.0010
203 INTENTIONAL UNDERDOSE 7 0.0010
204 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
205 SCREAMING 6 0.0009
206 AORTIC VALVE INCOMPETENCE 4 0.0009
207 ORAL DISCOMFORT 13 0.0009
208 OVERWEIGHT 5 0.0009
209 PARANOIA 16 0.0009
210 GAIT INABILITY 31 0.0009
211 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
212 INFUSION SITE HAEMORRHAGE 3 0.0009
213 CONFUSIONAL STATE 147 0.0009
214 COLONOSCOPY 2 0.0009
215 PEPTIC ULCER 3 0.0009
216 BLOOD CREATINE INCREASED 4 0.0009
217 GASTRIC ULCER HAEMORRHAGE 5 0.0009
218 LYME DISEASE 3 0.0009
219 THERAPEUTIC AGENT TOXICITY 3 0.0009
220 TERMINAL STATE 6 0.0009
221 POTENTIATING DRUG INTERACTION 3 0.0009
222 FEAR OF DEATH 2 0.0009
223 SPEECH DISORDER 46 0.0009
224 CERVICAL VERTEBRAL FRACTURE 3 0.0009
225 ABNORMAL DREAMS 24 0.0009
226 DROOLING 6 0.0009
227 FLAT AFFECT 2 0.0009
228 DISORIENTATION 34 0.0009
229 BILIRUBIN CONJUGATED INCREASED 2 0.0009
230 HYPOVOLAEMIA 5 0.0009
231 INCONTINENCE 9 0.0009
232 SUDDEN DEATH 9 0.0008
233 SPINAL COLUMN STENOSIS 4 0.0008
234 PSYCHOTIC DISORDER 25 0.0008
235 GLOSSITIS 3 0.0008
236 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
237 DEVICE PLACEMENT ISSUE 3 0.0008
238 FACIAL BONES FRACTURE 3 0.0008
239 BONE LESION 3 0.0008
240 HEAD INJURY 26 0.0008
241 FACIAL PARALYSIS 7 0.0008
242 DERMAL CYST 2 0.0008
243 SKIN HAEMORRHAGE 12 0.0008
244 NIGHTMARE 28 0.0008
245 TREMOR 134 0.0008
246 GASTROINTESTINAL TUBE INSERTION 2 0.0008
247 PRE-EXISTING CONDITION IMPROVED 5 0.0008
248 IMPULSIVE BEHAVIOUR 3 0.0008
249 COGNITIVE DISORDER 37 0.0008
250 ENDODONTIC PROCEDURE 2 0.0008
251 DYSLIPIDAEMIA 4 0.0008
252 ANGLE CLOSURE GLAUCOMA 2 0.0008
253 INITIAL INSOMNIA 8 0.0008
254 CONCUSSION 6 0.0008
255 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
256 PANIC DISORDER 3 0.0008
257 INCOHERENT 5 0.0008
258 EPIGASTRIC DISCOMFORT 3 0.0008
259 AFFECTIVE DISORDER 6 0.0008
260 WALKING AID USER 5 0.0008
261 PRODUCT DISTRIBUTION ISSUE 7 0.0008
262 BLOOD PRESSURE FLUCTUATION 18 0.0007
263 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
264 SQUAMOUS CELL CARCINOMA 7 0.0007
265 BLOOD SODIUM INCREASED 2 0.0007
266 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
267 BEHAVIOUR DISORDER 4 0.0007
268 DECUBITUS ULCER 6 0.0007
269 FALL 245 0.0007
270 ASPIRATION 8 0.0007
271 MANIA 12 0.0007
272 HYPERKERATOSIS 4 0.0007
273 BLOOD PRESSURE DECREASED 48 0.0007
274 AGITATION 53 0.0007
275 CHOLECYSTITIS INFECTIVE 2 0.0007
276 URINARY RETENTION 24 0.0007
277 DIABETIC COMA 2 0.0007
278 ENDOTRACHEAL INTUBATION 2 0.0007
279 RESTLESSNESS 26 0.0007
280 DEPRESSED LEVEL OF CONSCIOUSNESS 28 0.0007
281 MITRAL VALVE INCOMPETENCE 8 0.0007
282 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
283 MICTURITION URGENCY 8 0.0007
284 MIDDLE INSOMNIA 13 0.0007
285 HORDEOLUM 3 0.0007
286 SLUGGISHNESS 7 0.0007
287 DEVICE POWER SOURCE ISSUE 2 0.0007
288 HAEMORRHAGIC ANAEMIA 3 0.0007
289 PNEUMONIA ASPIRATION 17 0.0007
290 DECREASED INTEREST 4 0.0007
291 ENERGY INCREASED 4 0.0007
292 CARDIOTOXICITY 6 0.0007
293 BALANCE DISORDER 58 0.0007
294 URINARY TRACT DISORDER 3 0.0007
295 PLATELET COUNT ABNORMAL 4 0.0007
296 DYSCHEZIA 2 0.0007
297 ENCEPHALOPATHY 16 0.0007
298 MENTAL STATUS CHANGES 18 0.0006
299 SCOLIOSIS 4 0.0006
300 FAMILY STRESS 2 0.0006
301 YELLOW SKIN 3 0.0006
302 BLEPHAROSPASM 4 0.0006
303 SPUTUM DISCOLOURED 6 0.0006
304 GAIT DISTURBANCE 121 0.0006
305 BILE DUCT STONE 2 0.0006
306 MOOD ALTERED 17 0.0006
307 PRESYNCOPE 15 0.0006
308 SOMNOLENCE 124 0.0006
309 FACET JOINT SYNDROME 2 0.0006
310 SOMNAMBULISM 4 0.0006
311 HYPOGAMMAGLOBULINAEMIA 4 0.0006
312 BREATH SOUNDS ABNORMAL 3 0.0006
313 HOSPICE CARE 6 0.0006
314 DIABETIC NEUROPATHY 3 0.0006
315 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
316 END STAGE RENAL DISEASE 11 0.0006
317 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
318 HYPERLIPIDAEMIA 7 0.0006
319 BLOOD SODIUM DECREASED 11 0.0006
320 DIFFICULTY IN WALKING 2 0.0006
321 ANURIA 5 0.0006
322 VARICOSE VEIN 3 0.0006
323 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
324 PANIC ATTACK 21 0.0006
325 URINARY TRACT INFECTION 98 0.0006
326 AORTIC STENOSIS 2 0.0006
327 CAROTID ARTERY STENOSIS 2 0.0006
328 HANGOVER 2 0.0006
329 EMBOLIC STROKE 2 0.0006
330 HAND FRACTURE 4 0.0006
331 SENSORY DISTURBANCE 9 0.0006
332 FACIAL PAIN 5 0.0006
333 CAROTID ARTERY OCCLUSION 2 0.0005
334 CUTANEOUS VASCULITIS 2 0.0005
335 DYSPHAGIA 52 0.0005
336 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
337 INCREASED TENDENCY TO BRUISE 5 0.0005
338 UNRESPONSIVE TO STIMULI 14 0.0005
339 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
340 PSYCHIATRIC SYMPTOM 4 0.0005
341 UROSEPSIS 5 0.0005
342 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
343 HEART RATE ABNORMAL 3 0.0005
344 THERAPEUTIC RESPONSE UNEXPECTED 24 0.0005
345 DYSARTHRIA 20 0.0005
346 DEPRESSED MOOD 28 0.0005
347 MOBILITY DECREASED 38 0.0005
348 CATHETER SITE INFECTION 2 0.0005
349 PERONEAL NERVE PALSY 3 0.0005
350 ECONOMIC PROBLEM 8 0.0005
351 CHRONIC KIDNEY DISEASE 40 0.0005
352 NEUROLOGICAL SYMPTOM 3 0.0005
353 MEMORY IMPAIRMENT 72 0.0005
354 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25 0.0005
355 AGGRESSION 26 0.0005
356 SINUS BRADYCARDIA 5 0.0005
357 RALES 3 0.0005
358 DIZZINESS POSTURAL 5 0.0005
359 HAEMORRHAGIC STROKE 4 0.0005
360 URINE ODOUR ABNORMAL 3 0.0005
361 PERIPHERAL COLDNESS 7 0.0005
362 RENAL TUBULAR NECROSIS 5 0.0005
363 CONSTIPATION 111 0.0005
364 HEAD DISCOMFORT 9 0.0005
365 PRODUCT DOSE OMISSION 33 0.0005
366 RENAL CYST 4 0.0005
367 HALLUCINATION, AUDITORY 8 0.0005
368 HYPERPHAGIA 2 0.0005
369 CARPAL TUNNEL SYNDROME 7 0.0005
370 SYNCOPE 50 0.0005
371 BLEPHARITIS 2 0.0005
372 MOVEMENT DISORDER 16 0.0005
373 SLEEP DISORDER 35 0.0005
374 FUNGAL SKIN INFECTION 2 0.0005
375 NOCTURIA 6 0.0005
376 ABNORMAL FAECES 4 0.0005
377 RIB FRACTURE 10 0.0005
378 MUSCULOSKELETAL STIFFNESS 42 0.0005
379 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
380 HAEMOGLOBIN ABNORMAL 3 0.0005
381 POOR QUALITY SLEEP 10 0.0005
382 DECREASED ACTIVITY 5 0.0005
383 DRUG INTERACTION 73 0.0005
384 BONE CANCER 2 0.0005
385 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
386 IMMOBILE 2 0.0005
387 DIVERTICULUM INTESTINAL 2 0.0005
388 NEUROTOXICITY 8 0.0005
389 DYSPHEMIA 2 0.0005
390 APPETITE DISORDER 3 0.0005
391 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
392 WRONG DRUG ADMINISTERED 4 0.0004
393 POST-TRAUMATIC STRESS DISORDER 3 0.0004
394 IMPAIRED GASTRIC EMPTYING 6 0.0004
395 ABDOMINAL HERNIA 2 0.0004
396 DISEASE COMPLICATION 2 0.0004
397 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
398 JOINT EFFUSION 3 0.0004
399 DEVICE ISSUE 39 0.0004
400 CONDITION AGGRAVATED 132 0.0004
401 IRON DEFICIENCY ANAEMIA 4 0.0004
402 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
403 POLLAKIURIA 18 0.0004
404 HYPOPHAGIA 11 0.0004
405 DUODENAL ULCER 3 0.0004
406 DIVERTICULUM 3 0.0004
407 ACUTE RESPIRATORY FAILURE 8 0.0004
408 IRRITABILITY 25 0.0004
409 PANIC REACTION 3 0.0004
410 GLAUCOMA 8 0.0004
411 TONGUE DISORDER 3 0.0004
412 HYPERCHOLESTEROLAEMIA 4 0.0004
413 MUSCULAR WEAKNESS 47 0.0004
414 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
415 ILL-DEFINED DISORDER 25 0.0004
416 MAJOR DEPRESSION 3 0.0004
417 CARDIOMEGALY 5 0.0004
418 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
419 SPINAL OPERATION 5 0.0004
420 URINARY INCONTINENCE 12 0.0004
421 TENDON RUPTURE 5 0.0004
422 ARTHROPOD BITE 3 0.0004
423 PRODUCT DOSE OMISSION ISSUE 119 0.0004
424 DELIRIUM 14 0.0004
425 THERAPEUTIC PRODUCT EFFECT DECREASED 18 0.0004
426 TOOTH EXTRACTION 5 0.0004
427 APHASIA 12 0.0004
428 EMPHYSEMA 4 0.0004
429 OSTEOPENIA 6 0.0004
430 DRY MOUTH 32 0.0004
431 ACIDOSIS 3 0.0004
432 EUPHORIC MOOD 4 0.0004
433 RENAL FAILURE CHRONIC 3 0.0004
434 CACHEXIA 2 0.0004
435 CEREBRAL ISCHAEMIA 2 0.0004
436 INSOMNIA 103 0.0004
437 FAILURE TO THRIVE 2 0.0004
438 KNEE ARTHROPLASTY 8 0.0004
439 SCRATCH 4 0.0004
440 DIZZINESS 189 0.0004
441 JOINT DISLOCATION 4 0.0004
442 OSTEOARTHRITIS 16 0.0004
443 EATING DISORDER 8 0.0004
444 THINKING ABNORMAL 7 0.0004
445 JOINT INJURY 8 0.0004
446 SENSORY LOSS 3 0.0004
447 FEAR 10 0.0004
448 MUSCLE DISORDER 3 0.0004
449 MUSCLE TIGHTNESS 6 0.0004
450 NEURALGIA 9 0.0004
451 FEELING JITTERY 7 0.0004
452 ABASIA 9 0.0004
453 CHOKING SENSATION 2 0.0004
454 STEVENS-JOHNSON SYNDROME 8 0.0004
455 NERVE INJURY 4 0.0004
456 PANCREATITIS 19 0.0004
457 FEELING COLD 10 0.0004
458 CHOKING 7 0.0004
459 MALNUTRITION 4 0.0004
460 NEPHROPATHY TOXIC 4 0.0004
461 BLOOD CALCIUM DECREASED 4 0.0004
462 RENAL FAILURE 47 0.0004
463 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
464 CHOLECYSTITIS ACUTE 2 0.0004
465 DISTURBANCE IN ATTENTION 19 0.0004
466 MYOCARDIAL ISCHAEMIA 4 0.0004
467 VITAMIN D DECREASED 3 0.0004
468 INTENTIONAL DOSE OMISSION 10 0.0004
469 INTERNAL HAEMORRHAGE 4 0.0003
470 MUSCULOSKELETAL DISCOMFORT 6 0.0003
471 MOOD SWINGS 11 0.0003
472 HYPERVENTILATION 2 0.0003
473 DEHYDRATION 46 0.0003
474 INJECTION SITE HAEMATOMA 5 0.0003
475 HYPERTRIGLYCERIDAEMIA 2 0.0003
476 HYPERCHLORHYDRIA 2 0.0003
477 LUNG INFILTRATION 3 0.0003
478 BLOOD IRON DECREASED 4 0.0003
479 CATARACT OPERATION 2 0.0003
480 RENAL INJURY 10 0.0003
481 PULMONARY MASS 5 0.0003
482 CARDIAC PACEMAKER INSERTION 2 0.0003
483 CEREBRAL HAEMORRHAGE 12 0.0003
484 ROAD TRAFFIC ACCIDENT 14 0.0003
485 ADVERSE DRUG REACTION 30 0.0003
486 WRIST FRACTURE 4 0.0003
487 ANAL INCONTINENCE 3 0.0003
488 TOOTHACHE 6 0.0003
489 OSTEOMYELITIS 6 0.0003
490 LOCALISED INFECTION 8 0.0003
491 MENTAL IMPAIRMENT 8 0.0003
492 BONE DISORDER 6 0.0003
493 RESPIRATORY FAILURE 24 0.0003
494 EXOSTOSIS 3 0.0003
495 TYPE 2 DIABETES MELLITUS 11 0.0003
496 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
497 HYPOTENSION 65 0.0003
498 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 23 0.0003
499 FEMUR FRACTURE 10 0.0003
500 PHARYNGITIS 4 0.0003
501 CYST 4 0.0003
502 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15 0.0003
503 DEFORMITY 3 0.0003
504 DEPRESSION 73 0.0003
505 BLOOD PRESSURE INCREASED 49 0.0003
506 BASAL CELL CARCINOMA 5 0.0003
507 ASTHENIA 120 0.0003
508 BRAIN FOG 5 0.0003
509 BLOOD URINE PRESENT 6 0.0003
510 RESPIRATORY TRACT CONGESTION 5 0.0003
511 INJECTION SITE IRRITATION 4 0.0003
512 LETHARGY 18 0.0003
513 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
514 LOSS OF CONSCIOUSNESS 40 0.0003
515 THROAT IRRITATION 14 0.0003
516 CONTUSION 30 0.0003
517 ATELECTASIS 3 0.0003
518 WITHDRAWAL SYNDROME 13 0.0003
519 LIVER FUNCTION TEST ABNORMAL 9 0.0003
520 ABDOMINAL DISTENSION 32 0.0003
521 NERVOUSNESS 16 0.0003
522 KNEE OPERATION 3 0.0003
523 JOINT STIFFNESS 8 0.0003
524 BEDRIDDEN 4 0.0003
525 NECK PAIN 17 0.0003
526 VENTRICULAR TACHYCARDIA 5 0.0003
527 GENERAL PHYSICAL HEALTH DETERIORATION 35 0.0003
528 BLOOD PRESSURE ABNORMAL 6 0.0003
529 BRADYCARDIA 16 0.0003
530 UPPER LIMB FRACTURE 6 0.0003
531 BLOOD POTASSIUM DECREASED 9 0.0003
532 BRAIN INJURY 3 0.0003
533 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
534 FEELING ABNORMAL 71 0.0003
535 BODY TEMPERATURE INCREASED 6 0.0003
536 COMA 14 0.0003
537 TREATMENT NONCOMPLIANCE 16 0.0003
538 BLOOD TESTOSTERONE DECREASED 2 0.0003
539 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
540 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
541 DYSPHONIA 17 0.0003
542 ENCEPHALITIS 2 0.0003
543 VENTRICULAR EXTRASYSTOLES 3 0.0003
544 EYE DISCHARGE 3 0.0003
545 DEVICE DEFECTIVE 5 0.0003
546 DEATH 248 0.0003
547 UNDERDOSE 21 0.0003
548 ACUTE KIDNEY INJURY 44 0.0003
549 APHONIA 4 0.0003
550 FOLLICULITIS 3 0.0003
551 DEVICE USE ISSUE 5 0.0003
552 PERIPHERAL SWELLING 44 0.0003
553 INJURY 20 0.0003
554 HYPOXIA 10 0.0003
555 HYPOTHYROIDISM 9 0.0003
556 SUBDURAL HAEMATOMA 4 0.0003
557 PARALYSIS 4 0.0003
558 PHARYNGITIS STREPTOCOCCAL 3 0.0003
559 ANOSMIA 4 0.0003
560 SKIN LACERATION 3 0.0003
561 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
562 CRYING 10 0.0003
563 PULMONARY THROMBOSIS 3 0.0003
564 ANXIETY 78 0.0003
565 HYPERHIDROSIS 35 0.0003
566 DENTAL CARIES 3 0.0003
567 FOOT DEFORMITY 3 0.0003
568 HYPOPHOSPHATAEMIA 2 0.0003
569 FEELING DRUNK 2 0.0003
570 IMMUNODEFICIENCY 4 0.0003
571 BACTERIAL INFECTION 5 0.0003
572 PULMONARY OEDEMA 12 0.0003
573 ORAL PAIN 6 0.0003
574 HAEMORRHAGE INTRACRANIAL 4 0.0003
575 OSTEOPOROSIS 11 0.0003
576 SEDATION 7 0.0003
577 ANHEDONIA 7 0.0003
578 ANGER 9 0.0003
579 THERAPY INTERRUPTED 19 0.0003
580 CHROMATURIA 6 0.0003
581 HEART RATE IRREGULAR 6 0.0003
582 BLOOD COUNT ABNORMAL 4 0.0003
583 FOOT FRACTURE 5 0.0003
584 MUSCULOSKELETAL DISORDER 5 0.0003
585 OEDEMA PERIPHERAL 32 0.0003
586 SLEEP APNOEA SYNDROME 5 0.0003
587 FEELING HOT 16 0.0003
588 DISSOCIATION 2 0.0003
589 PULMONARY FIBROSIS 5 0.0003
590 DRY EYE 13 0.0003
591 MUSCLE TWITCHING 6 0.0003
592 LOWER LIMB FRACTURE 5 0.0003
593 PRESCRIBED OVERDOSE 5 0.0003
594 BLOOD CHOLESTEROL INCREASED 12 0.0003
595 SWOLLEN TONGUE 8 0.0003
596 SPLENOMEGALY 3 0.0003
597 FATIGUE 198 0.0003
598 THERAPY CESSATION 13 0.0003
599 BACTERAEMIA 3 0.0003
600 CHOLECYSTITIS 3 0.0003
601 GINGIVAL PAIN 2 0.0003
602 CYSTITIS 8 0.0003
603 FRUSTRATION TOLERANCE DECREASED 2 0.0002
604 BURSITIS 3 0.0002
605 PLEURAL EFFUSION 15 0.0002
606 BLOOD POTASSIUM INCREASED 4 0.0002
607 BACK DISORDER 4 0.0002
608 AMNESIA 16 0.0002
609 NAUSEA 194 0.0002
610 RED BLOOD CELL COUNT DECREASED 7 0.0002
611 METASTASES TO BONE 4 0.0002
612 PULMONARY EMBOLISM 23 0.0002
613 HAIR COLOUR CHANGES 3 0.0002
614 PNEUMONIA 78 0.0002
615 AGEUSIA 6 0.0002
616 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
617 DYSPNOEA EXERTIONAL 9 0.0002
618 POISONING 3 0.0002
619 COLITIS 9 0.0002
620 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
621 MUSCLE ATROPHY 3 0.0002
622 CARDIAC FAILURE CONGESTIVE 19 0.0002
623 HEMIPARESIS 4 0.0002
624 VISUAL IMPAIRMENT 29 0.0002
625 ROTATOR CUFF SYNDROME 3 0.0002
626 ABDOMINAL DISCOMFORT 39 0.0002
627 SKIN ULCER 6 0.0002
628 BLOOD MAGNESIUM DECREASED 2 0.0002
629 LACRIMATION INCREASED 7 0.0002
630 HIATUS HERNIA 3 0.0002
631 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
632 HYSTERECTOMY 2 0.0002
633 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
634 PRODUCTIVE COUGH 11 0.0002
635 BRONCHITIS 17 0.0002
636 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
637 DECREASED APPETITE 53 0.0002
638 BLOOD CALCIUM INCREASED 2 0.0002
639 GASTRITIS 6 0.0002
640 HEART RATE DECREASED 8 0.0002
641 GROIN PAIN 2 0.0002
642 PULMONARY CONGESTION 3 0.0002
643 GRIP STRENGTH DECREASED 2 0.0002
644 SARS-COV-2 TEST POSITIVE 3 0.0002
645 ADVERSE REACTION 3 0.0002
646 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
647 ATRIAL FIBRILLATION 22 0.0002
648 UNEVALUABLE EVENT 17 0.0002
649 SWELLING 21 0.0002
650 MALIGNANT MELANOMA 3 0.0002
651 QUALITY OF LIFE DECREASED 3 0.0002
652 GASTROINTESTINAL INFECTION 2 0.0002
653 FREQUENT BOWEL MOVEMENTS 6 0.0002
654 SINUS CONGESTION 3 0.0002
655 AKATHISIA 3 0.0002
656 GINGIVAL BLEEDING 3 0.0002
657 MUSCLE SPASMS 40 0.0002
658 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
659 DRUG INEFFECTIVE 285 0.0002
660 RHABDOMYOLYSIS 9 0.0002
661 HYPOMAGNESAEMIA 3 0.0002
662 HEPATIC STEATOSIS 4 0.0002
663 MASS 3 0.0002
664 HEPATIC ENCEPHALOPATHY 2 0.0002
665 PALPITATIONS 25 0.0002
666 CEREBROVASCULAR ACCIDENT 36 0.0002
667 ARTERIOSCLEROSIS 2 0.0002
668 STAPHYLOCOCCAL INFECTION 7 0.0002
669 SEASONAL ALLERGY 3 0.0002
670 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
671 PAIN IN JAW 6 0.0002
672 HEPATOCELLULAR INJURY 3 0.0002
673 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
674 VOMITING 99 0.0002
675 PROTEINURIA 4 0.0002
676 COUGH 59 0.0002
677 VIRAL INFECTION 7 0.0002
678 NEUROPATHY PERIPHERAL 20 0.0002
679 PRODUCT PRESCRIBING ERROR 5 0.0002
680 ANGINA PECTORIS 6 0.0002
681 HYPOACUSIS 9 0.0002
682 POST PROCEDURAL COMPLICATION 4 0.0002
683 AFFECT LABILITY 2 0.0002
684 TOXICITY TO VARIOUS AGENTS 35 0.0002
685 DEVICE LEAKAGE 9 0.0002
686 DEVICE DISLOCATION 9 0.0002
687 APATHY 3 0.0002
688 GASTROENTERITIS 3 0.0002
689 HAEMORRHOIDS 4 0.0002
690 LUNG DISORDER 10 0.0002
691 HEPATOMEGALY 2 0.0002
692 CARDIAC DISORDER 19 0.0002
693 EMBEDDED DEVICE 2 0.0002
694 HAEMATOCRIT DECREASED 4 0.0002
695 INABILITY TO AFFORD MEDICATION 2 0.0002
696 COLON CANCER 3 0.0002
697 HYPOAESTHESIA 30 0.0002
698 THERAPY NON-RESPONDER 9 0.0002
699 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36 0.0002
700 SPINAL FRACTURE 4 0.0002
701 SEIZURE 23 0.0002
702 PRODUCT PHYSICAL ISSUE 4 0.0002
703 HYPERTENSION 42 0.0002
704 BACK PAIN 46 0.0002
705 TASTE DISORDER 4 0.0002
706 WEIGHT DECREASED 55 0.0002
707 BLINDNESS 8 0.0002
708 PRODUCT ADHESION ISSUE 7 0.0002
709 HIP ARTHROPLASTY 3 0.0002
710 DRUG ADMINISTRATION ERROR 6 0.0002
711 ADVERSE EVENT 18 0.0002
712 THYROID DISORDER 3 0.0002
713 EMOTIONAL DISORDER 6 0.0002
714 FLATULENCE 11 0.0002
715 MUSCULOSKELETAL CHEST PAIN 3 0.0002
716 HYPERBILIRUBINAEMIA 2 0.0002
717 HAEMATOMA 5 0.0002
718 TOOTH LOSS 4 0.0002
719 DIPLOPIA 5 0.0002
720 PULMONARY HYPERTENSION 4 0.0002
721 DEAFNESS 5 0.0002
722 MOUTH ULCERATION 4 0.0002
723 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
724 PNEUMOTHORAX 3 0.0002
725 BODY HEIGHT DECREASED 2 0.0002
726 CARDIAC FAILURE 15 0.0002
727 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
728 BREAST CANCER METASTATIC 2 0.0002
729 DRUG EFFECT DECREASED 10 0.0002
730 BACK INJURY 2 0.0002
731 PALLOR 5 0.0002
732 PRODUCT DISPENSING ERROR 4 0.0002
733 MYOCARDIAL INFARCTION 32 0.0002
734 PAIN IN EXTREMITY 54 0.0002
735 DYSPEPSIA 18 0.0002
736 CARDIAC ARREST 15 0.0002
737 ABDOMINAL PAIN 42 0.0002
738 EXPIRED PRODUCT ADMINISTERED 6 0.0002
739 DISCOMFORT 11 0.0002
740 COAGULOPATHY 3 0.0002
741 MEDICATION ERROR 10 0.0002
742 TOOTH DISORDER 4 0.0002
743 HYPERTENSIVE CRISIS 2 0.0002
744 PLASMA CELL MYELOMA 7 0.0002
745 SEPSIS 20 0.0002
746 BLOOD UREA INCREASED 3 0.0002
747 RENAL IMPAIRMENT 15 0.0002
748 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
749 BLISTER 10 0.0002
750 PANCREATITIS ACUTE 4 0.0002
751 FISTULA 2 0.0002
752 CANDIDA INFECTION 3 0.0002
753 HYPONATRAEMIA 10 0.0002
754 TARDIVE DYSKINESIA 5 0.0002
755 EYE INFECTION 2 0.0002
756 FLUID RETENTION 9 0.0002
757 IMPAIRED DRIVING ABILITY 2 0.0002
758 PRODUCT AVAILABILITY ISSUE 4 0.0002
759 PRODUCT USE ISSUE 33 0.0002
760 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
761 HAEMATURIA 6 0.0002
762 ABDOMINAL PAIN UPPER 36 0.0002
763 GASTRIC DISORDER 6 0.0002
764 SKIN DISCOLOURATION 8 0.0002
765 MULTI-ORGAN FAILURE 3 0.0002
766 PRODUCT USE IN UNAPPROVED INDICATION 43 0.0002
767 HOT FLUSH 13 0.0002
768 LOCAL SWELLING 3 0.0002
769 MALAISE 75 0.0002
770 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
771 LYMPHADENOPATHY 6 0.0002
772 DRUG DOSE OMISSION 28 0.0002
773 HOSPITALISATION 26 0.0002
774 ATAXIA 2 0.0002
775 ISCHAEMIC STROKE 3 0.0002
776 CATARACT 10 0.0002
777 ANAEMIA 32 0.0002
778 BLOOD GLUCOSE DECREASED 8 0.0002
779 DRUG INTOLERANCE 16 0.0002
780 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
781 RENAL FAILURE ACUTE 7 0.0002
782 NASOPHARYNGITIS 30 0.0002
783 HYPERCALCAEMIA 2 0.0002
784 CONJUNCTIVITIS 3 0.0002
785 OSTEONECROSIS OF JAW 4 0.0002
786 LIMB DISCOMFORT 5 0.0002
787 GENERALISED OEDEMA 2 0.0002
788 SEPTIC SHOCK 7 0.0002
789 DISEASE PROGRESSION 19 0.0002
790 INTESTINAL OBSTRUCTION 6 0.0002
791 BRAIN OEDEMA 2 0.0002
792 GASTROINTESTINAL DISORDER 14 0.0002
793 RHINORRHOEA 10 0.0002
794 BONE PAIN 9 0.0002
795 INCORRECT DOSE ADMINISTERED 35 0.0002
796 ECZEMA 8 0.0002
797 APPLICATION SITE ERYTHEMA 4 0.0002
798 CHOLELITHIASIS 5 0.0002
799 THROMBOCYTOPENIA 17 0.0002
800 IMMUNE SYSTEM DISORDER 2 0.0002
801 HYPOKALAEMIA 7 0.0002
802 CHEST PAIN 28 0.0002
803 EAR INFECTION 4 0.0002
804 RENAL DISORDER 7 0.0002
805 LIP SWELLING 5 0.0001
806 EYE HAEMORRHAGE 2 0.0001
807 INTENTIONAL SELF-INJURY 3 0.0001
808 COVID-19 26 0.0001
809 DYSGEUSIA 11 0.0001
810 FEEDING DISORDER 3 0.0001
811 THROAT TIGHTNESS 4 0.0001
812 DEVICE BREAKAGE 6 0.0001
813 OCULAR HYPERAEMIA 7 0.0001
814 EPISTAXIS 11 0.0001
815 DYSPNOEA 83 0.0001
816 MULTIPLE SCLEROSIS 7 0.0001
817 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
818 HAEMOGLOBIN DECREASED 15 0.0001
819 CORONARY ARTERY OCCLUSION 2 0.0001
820 APPLICATION SITE RASH 2 0.0001
821 RESPIRATORY ARREST 4 0.0001
822 DIVERTICULITIS 4 0.0001
823 DIABETES MELLITUS 11 0.0001
824 COORDINATION ABNORMAL 2 0.0001
825 WEIGHT INCREASED 32 0.0001
826 HYPERKALAEMIA 5 0.0001
827 BLOOD TEST ABNORMAL 2 0.0001
828 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
829 RECTAL HAEMORRHAGE 6 0.0001
830 CARDIOGENIC SHOCK 2 0.0001
831 OVERDOSE 30 0.0001
832 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
833 ACCIDENTAL UNDERDOSE 2 0.0001
834 HYPERTHYROIDISM 2 0.0001
835 PRODUCT PRESCRIBING ISSUE 3 0.0001
836 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
837 FLUID OVERLOAD 2 0.0001
838 INTENTIONAL PRODUCT MISUSE 12 0.0001
839 DRUG WITHDRAWAL SYNDROME 12 0.0001
840 THROMBOSIS 11 0.0001
841 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
842 SURGERY 8 0.0001
843 NASAL CONGESTION 8 0.0001
844 ASCITES 4 0.0001
845 PAIN 82 0.0001
846 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 27 0.0001
847 APPLICATION SITE PRURITUS 3 0.0001
848 CORONARY ARTERY DISEASE 4 0.0001
849 DEVICE FAILURE 2 0.0001
850 INFECTION 19 0.0001
851 VISION BLURRED 18 0.0001
852 SUICIDAL IDEATION 12 0.0001
853 NEPHROLITHIASIS 6 0.0001
854 DEVICE RELATED INFECTION 2 0.0001
855 ANKLE FRACTURE 2 0.0001
856 RASH PRURITIC 7 0.0001
857 BURNING SENSATION 9 0.0001
858 PARAESTHESIA 20 0.0001
859 HEADACHE 79 0.0001
860 ARTHROPATHY 7 0.0001
861 ABSCESS 2 0.0001
862 METABOLIC ACIDOSIS 4 0.0001
863 INTENTIONAL OVERDOSE 8 0.0001
864 EYE PAIN 7 0.0001
865 INTERSTITIAL LUNG DISEASE 6 0.0001
866 TACHYCARDIA 11 0.0001
867 IMPAIRED HEALING 4 0.0001
868 DEVICE DIFFICULT TO USE 8 0.0001
869 EXTRAPYRAMIDAL DISORDER 3 0.0001
870 CARDIO-RESPIRATORY ARREST 5 0.0001
871 CHILLS 14 0.0001
872 FLUSHING 12 0.0001
873 WHEEZING 7 0.0001
874 ARTHRALGIA 49 0.0001
875 CHEST DISCOMFORT 12 0.0001
876 ILLNESS 12 0.0001
877 INFLAMMATION 6 0.0001
878 STOMATITIS 7 0.0001
879 RESPIRATORY TRACT INFECTION 3 0.0001
880 MENTAL DISORDER 5 0.0001
881 VERTIGO 7 0.0001
882 MUSCULOSKELETAL PAIN 6 0.0001
883 ARTHRITIS 9 0.0001
884 DIARRHOEA 73 0.0001
885 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
886 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
887 JAUNDICE 3 0.0001
888 GOUT 2 0.0001
889 SKIN LESION 3 0.0001
890 ACCIDENTAL OVERDOSE 4 0.0001
891 TINNITUS 5 0.0001
892 RESPIRATORY DISTRESS 3 0.0001
893 DYSURIA 4 0.0001
894 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
895 JOINT SWELLING 13 0.0001
896 EYE SWELLING 4 0.0001
897 OFF LABEL USE 94 0.0001
898 SINUSITIS 11 0.0001
899 HEPATIC CIRRHOSIS 2 0.0001
900 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
901 FRACTURE 2 0.0001
902 GASTRIC ULCER 2 0.0001
903 MIGRAINE 10 0.0001
904 RASH ERYTHEMATOUS 5 0.0001
905 HERPES ZOSTER 6 0.0001
906 INJECTION SITE SWELLING 8 0.0001
907 EYE IRRITATION 6 0.0001
908 EAR PAIN 2 0.0001
909 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
910 LABORATORY TEST ABNORMAL 3 0.0001
911 DISABILITY 2 0.0001
912 HEPATIC FAILURE 3 0.0001
913 RASH 43 0.0001
914 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
915 OROPHARYNGEAL PAIN 9 0.0001
916 ALOPECIA 19 0.0001
917 HAEMORRHAGE 10 0.0001
918 URTICARIA 16 0.0001
919 DERMATITIS 2 0.0001
920 PRURITUS 36 0.0001
921 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
922 FAECES DISCOLOURED 2 0.0001
923 OSTEONECROSIS 3 0.0001
924 EYE DISORDER 3 0.0001
925 ANAPHYLACTIC REACTION 5 0.0001
926 BLOOD GLUCOSE INCREASED 17 0.0001
927 FUNGAL INFECTION 3 0.0001
928 SKIN DISORDER 3 0.0001
929 HEPATOTOXICITY 2 0.0001
930 INFLUENZA 10 0.0001
931 PYREXIA 31 0.0001
932 GLOSSODYNIA 2 0.0001
933 OXYGEN SATURATION DECREASED 5 0.0001
934 INJECTION SITE HAEMORRHAGE 7 0.0001
935 ERYTHEMA 18 0.0001
936 CONVULSION 5 0.0001
937 RASH MACULAR 3 0.0001
938 TREATMENT FAILURE 7 0.0001
939 ARRHYTHMIA 4 0.0001
940 PSORIASIS 11 0.0001
941 DISEASE RECURRENCE 4 0.0001
942 DRUG EFFECT INCOMPLETE 3 0.0001
943 THERAPEUTIC RESPONSE DECREASED 5 0.0001
944 MYALGIA 14 0.0001
945 PRODUCT QUALITY ISSUE 11 0.0001
946 HEART RATE INCREASED 8 0.0001
947 CELLULITIS 4 0.0001
948 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
949 HAEMATEMESIS 2 0.0001
950 DRY SKIN 10 0.0001
951 EMOTIONAL DISTRESS 9 0.0001
952 LUNG NEOPLASM MALIGNANT 3 0.0001
953 INFLUENZA LIKE ILLNESS 6 0.0001
954 HAEMATOCHEZIA 4 0.0001
955 DRUG ABUSE 6 0.0001
956 NO ADVERSE EVENT 13 0.0001
957 HAEMOPTYSIS 2 0.0001
958 DEVICE MALFUNCTION 5 0.0001
959 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
960 ASTHMA 8 0.0001
961 HYPERSENSITIVITY 13 0.0001
962 PRODUCT STORAGE ERROR 6 0.0001
963 ACUTE MYOCARDIAL INFARCTION 2 0.0001
964 SUICIDE ATTEMPT 4 0.0001
965 HYPOGLYCAEMIA 3 0.0001
966 SWELLING FACE 4 0.0001
967 BLOOD CREATININE INCREASED 4 0.0001
968 LEUKOPENIA 3 0.0001
969 NEOPLASM MALIGNANT 4 0.0001
970 SKIN EXFOLIATION 5 0.0001
971 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
972 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
973 DEVICE USE ERROR 2 0.0001
974 DERMATITIS ATOPIC 3 0.0001
975 PLATELET COUNT DECREASED 6 0.0001
976 OEDEMA 3 0.0001
977 HEPATIC FUNCTION ABNORMAL 2 0.0001
978 PRODUCT SUBSTITUTION ISSUE 3 0.0001
979 NEUTROPENIA 7 0.0001
980 PROSTATE CANCER 4 0.0000
981 DEEP VEIN THROMBOSIS 3 0.0000
982 FEBRILE NEUTROPENIA 3 0.0000
983 INJECTION SITE PRURITUS 3 0.0000
984 COLITIS ULCERATIVE 2 0.0000
985 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
986 INJECTION SITE ERYTHEMA 5 0.0000
987 BREAST CANCER 3 0.0000
988 HEPATIC ENZYME INCREASED 2 0.0000
989 ACNE 2 0.0000
990 DRUG DEPENDENCE 4 0.0000
991 INJECTION SITE PAIN 7 0.0000
992 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000